Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Emilio Ledesma"'
Autor:
Kah Kee Tan, Duc Anh Dang, Ki Hwan Kim, Cissy Kartasasmita, Hwang Min Kim, Xu-Hao Zhang, Fakrudeen Shafi, Ta-Wen Yu, Emilio Ledesma, Nadia Meyer
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 1, Pp 95-105 (2018)
Background: Few studies describe the community-acquired pneumonia (CAP) burden in children in Asia. We estimated the proportion of all CAP hospitalizations in children from nine hospitals across the Republic of Korea (high-income), Indonesia, Malaysi
Externí odkaz:
https://doaj.org/article/a7f02d39014b4606b981460dcf70735c
Autor:
Duc Anh Dang, Cissy B. Kartasasmita, Xu-Hao Zhang, Emilio Ledesma, Ta-Wen Yu, Fakrudeen Shafi, Hwang Min Kim, Nadia Meyer, Kah Kee Tan, Ki Hwan Kim
Publikováno v:
Human Vaccines & Immunotherapeutics
Background: Few studies describe the community-acquired pneumonia (CAP) burden in children in Asia. We estimated the proportion of all CAP hospitalizations in children from nine hospitals across the Republic of Korea (high-income), Indonesia, Malaysi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59f99673dcfedfad6908e9c63b1bb0c0
http://europepmc.org/articles/PMC5791577
http://europepmc.org/articles/PMC5791577
Autor:
Yanfang Liu, Su Peing Ng, Maja Galic, Annmarie Pendleton, Christopher J.P. Clarke, Emilio Ledesma, Gunasekaran Ramakrishnan
Publikováno v:
Human Vaccines & Immunotherapeutics
This study was conducted to assess the impact of administration of two-dose rotavirus (RV) vaccine (RIX4414; GlaxoSmithKline Vaccines) among children aged less than 5 y in three states/territories of Australia. Aggregated and de-identified data on ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45bdccb0c70a5c73a42b150d2046db2f
https://doi.org/10.4161/hv.24831
https://doi.org/10.4161/hv.24831
Publikováno v:
Human Vaccines. 5:608-613
In response to increased demand for the 23-valent pneumococcal vaccine PNEUMOVAX II, a new manufacturing process has been implemented that improves the consistency and increases the scale of production. This double-blind, randomized, clinical study c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6da74eaf2d7fc91a00ddf96e60044c22
https://doi.org/10.4161/hv.9228
https://doi.org/10.4161/hv.9228
Autor:
Michael, Sension, Jose Luiz de, Andrade Neto, Beatriz, Grinsztejn, Jean Michel, Molina, Isidro, Zavala, Juan, González-García, Alice, Donnelly, Phillip, Phiri, Emilio, Ledesma, Donnie, McGrath, Frederico, Rangel
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 51:153-162
The following members of the 067 Study Group participated in subject recruitment, enrollment, medical management, and data collection: William Powderly, MD, St. Louis, MO; Joseph Jemsek, MD, Huntersville, NC; Robert Eng, MD, East Orange, NJ; Dorece N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb286b047d4fba1f2f4c66ad20c27132
https://doi.org/10.1097/qai.0b013e3181a5701c
https://doi.org/10.1097/qai.0b013e3181a5701c
Autor:
Monique Van den Dungen, Claudia Gruber, Emilio Ledesma, Francisco Antunes, Linda Odeshoo, Adriano Lazzarin, Clifford Leen, Eric Van Wijngaerden, Andrzej Horban, Victoria Wirtz, Dominique Salmon Ceron, José M. Gatell
Publikováno v:
Clinical Infectious Diseases. 44:1484-1492
BACKGROUND Atazanavir is a once-daily protease inhibitor (PI) for the treatment of human immunodeficiency virus (HIV) infection that has previously been studied in cohorts of treatment-naive and treatment-experienced patients. Limited data are availa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::830d4bd4d4a5c4299b594ec4891623a4
https://doi.org/10.1086/517497
https://doi.org/10.1086/517497
Autor:
Pirmin Habermehl, Yves Gillet, Anne Fiquet, Emilio Ledesma, Stéphane Thomas, Cécile Eymin, Isabelle Bertrand
Publikováno v:
Pediatrics. 121:S164-S164
INTRODUCTION: In Europe, recommended administration route for vaccines and physicians' preferences vary. OBJECTIVE: The aim of this study was to compare the immunogenicity and safety profile (injection-site and systemic adverse events) of a measles-m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05524b3ff72e653cc3e2fe8a17be9d66
https://doi.org/10.1542/peds.2007-2022rrrrrrr
https://doi.org/10.1542/peds.2007-2022rrrrrrr
Autor:
Emilio Ledesma, Vicente Soriano
Publikováno v:
AIDS. 13:1998
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d1aa182e98852505cbcc53d0fbc7958
https://doi.org/10.1097/00002030-199910010-00037
https://doi.org/10.1097/00002030-199910010-00037
Autor:
Anne Fiquet, Patrick Richard, Emilio Ledesma, Sandrine I. Samson, Gilles Meghlaoui, Pierre Van Damme, Robert Arnou, Froukje Kafeja, Stéphane Thomas
Publikováno v:
BMC Infectious Diseases, Vol 10, Iss 1, p 134 (2010)
BMC infectious diseases
BMC Infectious Diseases
BMC infectious diseases
BMC Infectious Diseases
Background Although seasonal influenza vaccine is effective in the elderly, immune responses to vaccination are lower in the elderly than in younger adults. Strategies to optimise responses to vaccination in the elderly include using an adjuvanted va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc1d73c033ab587c3304151eef3d5c91